Abstract
Pancreatic cancer is one of the five leading causes of cancer death for both males and females in the western world. More than 85 % pancreatic tumors are of ductal origin but the incidence of cystic tumors such as intrapapillary mucinous tumors (IPMN) or mucinous cystic tumors (MCN) and other rare tumors is rising. Complete surgical resection of the tumor is the mainstay of any curative therapeutic approach, however, up to 40 % of patients with potentially resectable pancreatic cancer are not offered surgery. This is despite 5-year survival rates of up to 40 % or even higher in selected patients depending on tumor stage and histology. Standard procedures for pancreatic tumors include the Kausch-Whipple- or pylorus-preserving Whipple procedure, and the left lateral pancreatic resection (often with splenectomy), and usually include regional lymphadenectomy. More radical or extended pancreatic operations are becoming increasingly utilised however and we examine the data available for their role. These operations include major venous and arterial resection, multivisceral resections and surgery for metastatic disease, or palliative pancreatic resection. Portal vein resection for local infiltration with or without replacement graft is now well established and does not deleteriously affect perioperative morbidity or mortality. Arterial resection, however, though often technically feasible, has questionable oncologic impact, is not without risk and is usually reserved for isolated cases. The value of extended lymphadenectomy is frequently debated; the recent level I evidence demonstrates no advantage. Multivisceral resections, i.e. tumors, often in the tail of the pancreas, with invasion of the colon or stomach or other surrounding tissues, while associated with an increased morbidity and a longer hospital stay, do however show comparable mortality—and survival rates to those without such infiltration and therefore should be performed if technically feasible. Routine resection for metastatic disease however does not seem to show any advantage over palliative treatment but may be an option in selected patients with easily removable metastases. In conclusion pancreatic surgery beyond the traditional limits is established in tumors infiltration the venous system and may be a considered approach in selected patients with locally infiltrating pancreatic cancer or metastasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bachellier P, Rosso E, Lucescu I et al (2011) Is the need for an arterial resection a contraindication to pancreatic resection for locally advanced pancreatic adenocarcinoma? A case-matched controlled study. J Surg Oncol 103:75–84
Beger HG, Büchler M (1989) Chronic pancreatitis: indications and successes of surgical therapy. Z Gastroenterol Verh 24:107–110
Bickenbach KA, Gonen M, Tang LH et al. (2011) Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease. Ann Surg Oncol Dec 1. [Epub ahead of print]
Birkmeyer JD, Sun Y, Wong SL et al (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245:777–783
Bockhorn M, Burdelski C, Bogoevski D et al (2011) Arterial en bloc resection for pancreatic carcinoma. Br J Surg 98:86–92
Bold RJ, Charnsangavej C, Cleary KR (1999) Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 3:233–243
Büchler MW, Wagner M, Schmied BM et al (2003) Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 138:1310–1314 discussion 1315
Buchs NC, Chilcott M, Poletti P-A et al (2010) Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management. World J Gastroenterol 21(16):818–831
Cameron JL, Riall TS, Coleman J et al (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10–15
Carrère N, Abid S, Julio CH et al (2007) Spleen-preserving distal pancreatectomy with excision of splenic artery and vein: a case-matched comparison with conventional distal pancreatectomy with splenectomy. World J Surg 31:375–382
Cusack JC Jr, Fuhrman GM, Lee JE et al (1994) Managing unsuspected tumor invasion of the superior mesenteric-portal venous confluence during pancreaticoduodenectomy. Am J Surg 168:352–354
Dalla Valle R, Mancini C, Crafa P et al (2006) Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy. JOP 7:473–477
Diener MK, Knaebel H-P, Heukaufer C et al (2007) A systematic review and meta-analysis of pylorus-preserving versus classical pancreaticoduodenectomy for surgical treatment of periampullary and pancreatic carcinoma. Ann Surg 245:187–200
Farnell MB, Pearson RK, Sarr MG et al (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618–628 discussion 628–630
Fortner JG (1973) Regional resection of cancer of the pancreas: a new surgical approach. Surgery 73:307–320
Fukuda S, Oussoultzoglou E, Bachellier P et al (2007) Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg 142:172–179
Fuhrman GM, Charnsangavej C, Abbruzzese JL et al (1994) Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg 167:104–111 discussion 111–113
Gagandeep S, Artinyan A, Jabbour N et al (2006) Extended pancreatectomy with resection of the celiac axis: the modified Apple by operation. Am J Surg 192:330–335
Gillen S, Schuster T, Meyer ZBC et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7(4):e1000267
Glanemann M, Shi B, Liang F et al (2008) Surgical strategies for treatment of malignant pancreatic tumors: extended, standard or local surgery? World J Surg Oncol 6:123
Habermehl D, Kessel K, Welzel T et al (2012) Neoadjuvant chemoradiation with gemcitabine for locally advanced pancreatic cancer. Radiat Oncol 2(7):28
Hackert T, Hinz U, Fritz S et al (2011) Enucleation in pancreatic surgery: indications, technique, and outcome compared to standard pancreatic resections. Langenbecks Arch Surg 396:1197–1203
Harrison LE, Klimstra DS, Brennan MF (1996) Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 224:342–347
Hartwig W, Hackert T, Hinz U et al (2009) Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 250:81–87
Hartwig W, Hackert T, Hinz U et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311–319
Hirano S, Kondo S, Hara T et al (2007) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer: long-term results. Ann Surg 246:46–51
Hishinuma S, Ogata Y, Tomikawa M et al (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10:511–518
Horton KM, Fishman EK (2002) Multidetector CT angiography of pancreatic carcinoma: part 2, evaluation of venous involvement. AJR Am J Roentgenol 178:833–836
Iqbal N, Lovegrove RE, Tilney HS et al (2009) A comparison of pancreaticoduodenectomy with extended pancreaticoduodenectomy: a meta-analysis of 1909 patients. Eur J Surg Oncol 35:79–86
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61:69–90
Kleeff J, Michalski CW, Friess H et al (2007a) Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. Eur J Surg Oncol 33:817–823
Kleeff J, Reiser C, Hinz U et al (2007b) Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg 245:566–572
Koniaris LG, Staveley-O’Carroll KF, Zeh HJ et al (2005) Pancreaticoduodenectomy in the presence of superior mesenteric venous obstruction. J Gastrointest Surg 9:915–921
Märten A, Schmidt J, Ose J et al (2009) A randomized multicentre phase II trial comparing adjuvant therapy in patients with interferon alpha-2b and 5-FU alone or in combination with either external radiation treatment and cisplatin (CapRI) or radiation alone regarding event-free survival—CapRI-2. BMC Cancer 9:160
Martin RF, Rossi RL, Leslie KA (1996) Long-term results of pylorus-preserving pancreatoduodenectomy for chronic pancreatitis. Arch Surg 131:247–252
Michalski CW, Kleeff J, Wente MN et al (2007) Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 94:265–273
Michalski CW, Erkan M, Hüser N et al (2008) Resection of primary pancreatic cancer and liver metastasis: a systematic review. Dig Surg 25:473–480
Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254:882–893
Morrow CE, Cohen JI, Sutherland DE et al (1984) Chronic pancreatitis: long-term surgical results of pancreatic duct drainage, pancreatic resection, and near-total pancreatectomy and islet autotransplantation. Surgery 96:608–616
Müller MW, Friess H, Kleeff J et al (2006) Middle segmental pancreatic resection: an option to treat benign pancreatic body lesions. Ann Surg 244:909–918 discussion 918–920
Müller MW, Friess H, Kleeff J et al (2007) Is there still a role for total pancreatectomy? Ann Surg 246:966–974 discussion 974–975
Müller SA, Hartel M, Mehrabi A et al (2009) Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg 13:784–792
Nakao A, Harada A, Nonami T et al (1996) Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 12:357–361
Neoptolemos JP, Stocken DD, Friess H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 18(350):1200–1210
Nikfarjam M, Sehmbey M, Kimchi ET et al (2009) Additional organ resection combined with pancreaticoduodenectomy does not increase postoperative morbidity and mortality. J Gastrointest Surg 13:915–921
Nimura Y, Nagino M, Takao S et al. (2011) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 2011 Oct 25. [Epub ahead of print]
Ogino T, Ueda J, Sato N et al (2010) Repeated pancreatectomy for recurrent pancreatic carcinoma after pylorus-preserving pancreatoduodenectomy: report of two patients. Case Rep Gastroenterol 4:429–434
Pedrazzoli S, DiCarlo V, Dionigi R et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517
Pitt SC, Pitt HA, Baker MS et al (2009) Small pancreatic and periampullary neuroendocrine tumors: resect or enucleate? J Gastrointest Surg 13:1692–1698
Pyke CM, van Heerden JA, Colby TV et al (1992) The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg 215:132–139
Reddy SK, Tyler DS, Pappas TN et al (2007) Extended resection for pancreatic adenocarcinoma. Oncologist 12:654–663
Reiser-Erkan C, Gaa J, Kleeff J (2008) T1 pancreatic cancer with lymph node metastasis and perineural invasion of the celiac trunk. Clin Gastroenterol Hepatol 6:e41–e42
Riediger H, Makowiec F, Fischer E et al (2006) Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection. J Gastrointest Surg 10:1106–1115
Rupp CC, Linehan DC (2009) Extended lymphadenectomy in the surgery of pancreatic adenocarcinoma and its relation to quality improvement issues. J Surg Oncol 15(99):207–214
Sasson AR, Hoffman JP, Ross EA et al (2002) En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J Gastrointest Surg 6:147–157 discussion 157–158
Shah OJ, Robbani I, Nazir P et al (2009) Central pancreatectomy: a new technique for resection of selected pancreatic tumors. HBPD INT 8:93–96
Shibata C, Kobari M, Tsuchiya T et al (2001) Pancreatectomy combined with superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 25:1002–1005
Shimada K, Sano T, Sakamoto Y et al (2006) Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol 13:1569–1578
Shoup M, Conlon KC, Klimstra D et al (2003) Is extended resection for adenocarcinoma of the body or tail of the pancreas justified? J Gastrointest Surg 7:946–952 discussion 952
Shrikhande SV, Barreto SG (2010) Extended pancreatic resections and lymphadenectomy: an appraisal of the current evidence. World J Gastrointest Surg 27(2):39–46
Shrikhande SV, Kleeff J, Reiser C et al (2007) Pancreatic resection for M1 pancreatic ductal adenocarcinoma. Ann Surg Oncol 14:118–127
Siriwardana HPP, Siriwardena AK (2006) Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 93:662–673
Smeenk HG, Tran TCK, Erdmann J et al (2005) Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg 390:94–103
Sperti C, Beltrame V, Milanetto AC et al (2010) Parenchyma-sparing pancreatectomies for benign or border-line tumors of the pancreas. World J Gastrointest Oncol 2:272–281
Sperti C, Pasquali C, Piccoli A et al (1997) Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21:195–200
Stitzenberg KB, Watson JC, Roberts A et al (2008) Survival after pancreatectomy with major arterial resection and reconstruction. Ann Surg Oncol 15:1399–1406
Stojadinovic A, Brooks A, Hoos A et al (2003) An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg 196:954–964
Strasberg SM, Drebin JA, Soper NJ (1997) Evolution and current status of the Whipple procedure: an update for gastroenterologists. Gastroenterology 113:983–994
Takamatsu S, Ban D, Irie T et al (2005) Resection of a cancer developing in the remnant pancreas after a pancreaticoduodenectomy for pancreas head cancer. J Gastrointest Surg 9:263–269
Talamini MA, Moesinger R, Yeo CJ et al (1998) Cystadenomas of the pancreas: is enucleation an adequate operation? Ann Surg 227:896–903
Tanaka M, Chari S, Adsay V et al (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6:17–32
Tran KTC, Smeenk HG, van Eijck CHJ et al (2004) Pylorus preserving pancreaticoduodenectomy versus standard whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240:738–745
Tseng JF, Raut CP, Lee JE et al (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935–949 discussion 949–950
Van den Broeck A, Sergeant G, Ectors N et al (2009) Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma. Eur J Surg Oncol 35:600–604
Wagner M, Redaelli C, Lietz M et al (2004) Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586–594
Weitz J, Kienle P, Schmidt J et al (2007) Portal vein resection for advanced pancreatic head cancer. J Am Coll Surg 204:712–716
Werner J, Büchler MW (2011) Management of pancreatic cancer: recent advances. Dtsch Med Wochenschr 136:1807–1810
Werner J, Fritz S, Büchler MW (2012) Intraductal papillary mucinous neoplasms of the pancreas-a surgical disease. Nat Rev Gastroenterol Hepatol http://www.ncbi.nlm.nih.gov/pubmed/22392299
Wu YL, Yan HC, Chen LR et al (2007) Extended Appleby’s operation for pancreatic cancer involving celiac axis. J Surg Oncol 96:442–446 discussion 447
Yamada H, Hirano S, Tanaka E et al (2006) Surgical treatment of liver metastases from pancreatic cancer. HPB (Oxford) 8:85–88
Yekebas EF, Bogoevski D, Cataldegirmen G et al (2008) En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients. Ann Surg 247:300–309
Yeo CJ, Cameron JL, Sohn TA et al (1999) Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 229:613–622 discussion 622–624
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Müller, S.A., Tarantino, I., Martin, D.J., Schmied, B.M. (2012). Pancreatic Surgery: Beyond the Traditional Limits. In: Otto, F., Lutz, M. (eds) Early Gastrointestinal Cancers. Recent Results in Cancer Research, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31629-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-31629-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31628-9
Online ISBN: 978-3-642-31629-6
eBook Packages: MedicineMedicine (R0)